NEE
49
2
VNO
52
6
MAR
32
2
T
68
2
UAL
54
3
HRB
56
2
GOOG
50
4
ROST
52
2
PX
59
11
VMC
65
5
SIG
52
2
MNST
54
-5
NKE
21
3
PCG
61
2
SLB
53
3
TGNA
69
3
LUV
50
-2
GE
58
3
PCAR
31
3
RCL
62
3
NEE
49
2
VNO
52
6
MAR
32
2
T
68
2
UAL
54
3
HRB
56
2
GOOG
50
4
ROST
52
2
PX
59
11
VMC
65
5
SIG
52
2
MNST
54
-5
NKE
21
3
PCG
61
2
SLB
53
3
TGNA
69
3
LUV
50
-2
GE
58
3
PCAR
31
3
RCL
62
3
Financhill
Back

AIM ImmunoTech 10K Form

Sell
27

AIM
AIM ImmunoTech

Last Price:
$0.12
Seasonality Move:
13.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-05-17 10Q AIM/AIM ImmunoTech Quarterly
2021-03-31 10K AIM/AIM ImmunoTech Annual
2020-11-12 10Q AIM/AIM ImmunoTech Quarterly
2020-08-14 10Q AIM/AIM ImmunoTech Quarterly
2020-05-14 10Q AIM/AIM ImmunoTech Quarterly
2020-03-30 10K AIM/AIM ImmunoTech Annual

Receive AIM News And Ratings

See the #1 stock for the next 7 days that we like better than AIM

AIM Financial Statistics

Sales & Book Value

Annual Sales: $170K
Cash Flow: $-3.3M
Price / Cash Flow: 0
Annual Sales: $0.05
Price / Book: 2.68

Profitability

EPS (TTM): -0.47000
Net Income (TTM): $-23.9M
Gross Margin: $139K
Return on Equity: -256.33%
Return on Assets: -129.02%

AIM ImmunoTech Earnings Forecast

Key AIM ImmunoTech Financial Ratios

  • The Gross Profit Margin over the past 30 years for AIM is 81.76%.
  • The Selling, General & Administrative Expenses for AIM have been equal to 8,067.06% of Gross Profit Margin.
  • The Research & Development expenses have been 3,645.29% of Revenue.
  • The Net Earning history of AIM is -10,188.24% of Total Revenues.
  • Per Share Earnings over the last 30 years have been positive in 18 years.

AIM ImmunoTech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: AIM
CUSIP: 00901B
Website: aimimmuno.com

Debt

Debt-to-Equity Ratio: 0.94
Current Ratio: 0.75
Quick Ratio: 0.71

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AIM Technical Analysis vs Fundamental Analysis

Sell
27
AIM ImmunoTech (AIM) is a Sell

Is AIM ImmunoTech a Buy or a Sell?

  • AIM ImmunoTech stock is rated a Sell
    The current AIM ImmunoTech [AIM] share price is $0.13. The Score for AIM is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.